Your gift is 100% tax deductible
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Your gift enables us to support people with cancer and fund research breakthroughs.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
Gastrointestinal Neuroendocrine (Carcinoid) Tumors
After someone is diagnosed with a gastrointestinal (GI) carcinoid tumor, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
GI carcinoid tumors are typically given a clinical stage based on the results of any exams, biopsies, and imaging tests that might have been done (as described in Tests for Gastrointestinal Carcinoid Tumors. If surgery has been done, the pathologic stage (also called the surgical stage) can also be determined.
GI carcinoid tumors typically start in the inner lining of the wall of the GI tract. As they grow, they can spread into deeper layers of the GI tract. For most of the GI tract, these layers include:
Until recently there was no standard staging system for describing the spread of GI carcinoid tumors. Many doctors simply staged GI carcinoid tumors as localized, regional spread, and distant spread. This approach was fairly easy to understand and could be useful when determining treatment options.
The staging system most often used for GI carcinoid tumors is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced.
Once the T, N, and M categories of the cancer have been determined, this information is combined in a process called stage grouping to assign an overall stage. For more information, see Cancer Staging.
The main stages of GI carcinoid tumors in the TNM system range from I (1) through IV (4). Some stages might be divided further with letters (A, B, etc.). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage. Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
The system described below is the most recent AJCC system, effective January 2018. It includes lower-grade carcinoid tumors that start in the GI tract, but not other types of cancers that can start there. (For example, it doesn't include high-grade neuroendocrine carcinomas, or the more common types of stomach cancer or colorectal cancer, which have their own staging systems.)
The stages of GI carcinoid tumors are slightly different, based on which part of the GI tract the cancer starts in:
*Carcinoid tumors starting in the duodenum or ampulla of Vater are uncommon and have their own staging system, which is not included here.
GI carcinoid tumor staging with the TNM system can be complex. If you have any questions about your cancer's stage or what it means, ask your doctor to explain it to you in a way you understand.
AJCC stage |
Stage grouping |
Stage description* |
I |
T1 |
The tumor is no more than 1 centimeter (cm) across and has grown from the top layer of cells and into deeper layers, such as the lamina propria or the submucosa (T1). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
II |
T2 |
The tumor has grown into the lamina propria or submucosa (or both) and is greater than 1 cm across; OR the tumor has grown into the main muscle layer of the stomach (the muscularis propria) (T2). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
T3 |
The tumor has grown through the muscularis propria and into the subserosa (T3). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
|
III |
T4 |
The tumor has grown into the outer layer of tissue covering the stomach (the serosa or visceral peritoneum) or into nearby organs or structures (T4). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It has spread to nearby lymph nodes (N1), but not to distant parts of the body (M0). |
|
IV |
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It might or might not have spread to nearby lymph nodes (any N). The cancer has spread to distant parts of the body (M1). |
*The following additional categories are not listed in the table above:
AJCC stage |
Stage grouping |
Stage description* |
I |
T1 |
The tumor is no more than 1 centimeter (cm) across and has grown from the top layer of cells and into deeper layers, such as the lamina propria or the submucosa (T1). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
II |
T2 |
The tumor has grown into the lamina propria or submucosa (or both) and is greater than 1 cm across; OR the tumor has grown into the main muscle layer of the intestine (the muscularis propria) (T2). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
T3 |
The tumor has grown through the muscularis propria and into the subserosa (T3). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
|
III |
T4 |
The tumor has grown into the outer layer of tissue covering the intestine (the serosa or visceral peritoneum) or into nearby organs or structures (T4). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It has spread to nearby lymph nodes (N1 or N2), but not to distant parts of the body (M0). |
|
IV |
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It might or might not have spread to nearby lymph nodes (any N). The cancer has spread to distant parts of the body (M1). |
*The following additional categories are not listed in the table above:
AJCC stage |
Stage grouping |
Stage description* |
I |
T1 |
The tumor is no more than 2 centimeters (cm) across (T1). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
II |
T2 |
The tumor is more than 2 cm but no more than 4 cm across (T2). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
T3 |
The tumor is more than 4 cm across, OR it has grown into the subserosa or the mesoappendix (T3). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
|
III |
T4 |
The tumor has grown into the outer layer of tissue covering the appendix (the peritoneum) or into nearby organs or structures (T4). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
OR |
||
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It has spread to nearby lymph nodes (N1), but not to distant parts of the body (M0). |
|
IV |
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It might or might not have spread to nearby lymph nodes (any N). The cancer has spread to distant parts of the body (M1). |
*The following additional categories are not listed in the table above:
AJCC stage |
Stage grouping |
Stage description* |
I |
T1 |
The tumor is no more than 2 centimeters (cm) across and has grown from the top layer of cells and into deeper layers, such as the lamina propria or the submucosa (T1). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IIA |
T2 |
The tumor has grown into the lamina propria or submucosa (or both) and is greater than 2 cm across; OR the tumor has grown into the main muscle layer (the muscularis propria) (T2). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IIB |
T3 |
The tumor has grown through the muscularis propria and into the subserosa (T3). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IIIA |
T4 |
The tumor has grown into the outer layer of tissue covering the intestine (the serosa or visceral peritoneum) or into nearby organs or structures (T4). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0). |
IIIB |
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It has spread to nearby lymph nodes (N1), but not to distant parts of the body (M0). |
IV |
Any T |
The tumor can be any size and might or might not have grown into nearby structures (any T). It might or might not have spread to nearby lymph nodes (any N). The cancer has spread to distant parts of the body (M1). |
*The following additional categories are not listed in the table above:
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Joint Committee on Cancer. Neuroendocrine Tumors of the Appendix. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 389-394.
American Joint Committee on Cancer. Neuroendocrine Tumors of the Colon and Rectum. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 395-406.
American Joint Committee on Cancer. Neuroendocrine Tumors of the Jejunum and Ileum. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 375-487.
American Joint Committee on Cancer. Neuroendocrine Tumors of the Stomach. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 351-359.
Last Revised: September 24, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
We fund research breakthroughs that save lives. Your year-end gift helps find new treatments for cancer.